Relation between soluble ST2, growth differentiation factor–15, and high-sensitivity troponin I and incident atrial fibrillation - 10/12/13
, Xiaoyan Yin, PhD c, d, Martin G. Larson, ScD c, d, João D. Fontes, MD, MPH c, e, Jared W. Magnani, MD, MS c, e, David D. McManus, MD, ScM f, Elizabeth L. McCabe, MS g, Erin E. Coglianese, MD g, h, Michael Amponsah, MD i, Jennifer E. Ho, MD c, e, James L. Januzzi, MD g, Kai C. Wollert, MD j, Michael G. Fradley, MD g, Ramachandran S. Vasan, MD c, e, k, l, Patrick T. Ellinor, MD, PhD a, g, Thomas J. Wang, MD c, m, Emelia J. Benjamin, MD, ScM c, e, k, lRésumé |
Background |
We investigated whether circulating concentrations of soluble ST2, growth differentiation factor–15 (GDF-15), and high-sensitivity troponin I (hsTnI) are associated with incident atrial fibrillation (AF) and whether these biomarkers improve current risk prediction models including AF risk factors, B-type natriuretic peptide (BNP), and C-reactive protein (CRP).
Methods |
We studied the relation between soluble ST2, GDF-15, and hsTnI and development of AF in Framingham Heart Study participants without prevalent AF. We used Cox proportional hazard regression analysis to examine the relation of incident AF during a 10-year follow-up period with each biomarker. We adjusted for standard AF clinical risk factors, BNP, and CRP.
Results |
The mean age of the 3,217 participants was 59 ± 10 years, and 54% were women. During a 10-year follow-up, 242 participants developed AF. In age- and sex-adjusted models, GDF-15 and hsTnI were associated with risk of incident AF; however, after including the AF risk factors and BNP and CRP, only hsTnI was significantly associated with AF (hazard ratio per 1 SD of loge hsTnI, 1.12, 95% CI 1.00-1.26, P = .045). The c statistic of the base model including AF risk factors, BNP, and CRP was 0.803 (95% CI 0.777-0.830) and did not improve by adding individual or all 3 biomarkers. None of the discrimination and reclassification statistics were significant compared with the base model.
Conclusion |
In a community-based cohort, circulating hsTnI concentrations were associated with incident AF. None of the novel biomarkers evaluated improved AF risk discrimination or reclassification beyond standard clinical AF risk factors and biomarkers.
Le texte complet de cet article est disponible en PDF.Plan
Vol 167 - N° 1
P. 109 - janvier 2014 Retour au numéro
Article précédent
- Genetic variation in the ?1-adrenergic receptor is associated with the risk of atrial fibrillation after cardiac surgery
- Janina M. Jeff, Brian S. Donahue, Kristin Brown-Gentry, Dan M. Roden, Dana C. Crawford, C. Michael Stein, Daniel Kurnik
- Gene-environment interaction between SCN5A-1103Y and hypokalemia influences QT interval prolongation in African Americans: The Jackson Heart Study
- Ermeg L. Akylbekova, John P. Payne, Christopher Newton-Cheh, Warren L. May, Ervin R. Fox, James G. Wilson, Daniel F. Sarpong, Herman A. Taylor, Joseph F. Maher
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?